← Back to Search

Behavioural Intervention

Mobile Health Technology for Atrial Fibrillation (mTECHAFib Trial)

N/A
Recruiting
Led By David Spragg, MD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

mTECHAFib Trial Summary

This trial will test a new digital toolkit to help manage atrial fibrillation and improve quality of life.

Who is the study for?
This trial is for adults over 18 with a recent diagnosis of non-valvular Paroxysmal Atrial Fibrillation. It's not suitable for those with certain heart conditions, physical or mental impairments that prevent using technology, severe hypertension, visual/hearing issues, or a history of serious cardiac events.Check my eligibility
What is being tested?
The study tests the Corrie Virtual Atrial Fibrillation Management Program—a digital tool designed to help patients manage AFib by educating them and guiding them during episodes. The program aims to improve quality of life and reduce AFib burden in a pilot randomized clinical trial.See study design
What are the potential side effects?
Since this intervention involves a digital management tool rather than medication, traditional side effects are not applicable. However, users may experience stress or frustration if they encounter difficulties using the technology.

mTECHAFib Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

mTECHAFib Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Feasibility as assessed by the retention rate
Secondary outcome measures
Alcohol use as assessed by the Alcohol Use Disorders Identification Test
Anxiety as assessed by the Generalized Anxiety Disorder 7 score
Atrial Fibrillation Episode Burden
+11 more

mTECHAFib Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Corrie Virtual Atrial Fibrillation Management ProgramExperimental Treatment1 Intervention
Multicomponent virtual atrial fibrillation management program
Group II: Usual CareActive Control1 Intervention
Receives usual care. Usual care is defined as care according to the patients care team's standard practice

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,275 Previous Clinical Trials
14,840,538 Total Patients Enrolled
11 Trials studying Atrial Fibrillation
7,549 Patients Enrolled for Atrial Fibrillation
David Spragg, MDPrincipal InvestigatorJohns Hopkins University
2 Previous Clinical Trials
260 Total Patients Enrolled
2 Trials studying Atrial Fibrillation
260 Patients Enrolled for Atrial Fibrillation

Media Library

Corrie Virtual Atrial Fibrillation Management Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05400837 — N/A
Atrial Fibrillation Research Study Groups: Corrie Virtual Atrial Fibrillation Management Program, Usual Care
Atrial Fibrillation Clinical Trial 2023: Corrie Virtual Atrial Fibrillation Management Program Highlights & Side Effects. Trial Name: NCT05400837 — N/A
Corrie Virtual Atrial Fibrillation Management Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05400837 — N/A
~0 spots leftby Jul 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top